The Ultimate Guide to Colon Cancer

The quick version

• Colon cancer is Australia's second deadliest cancer, but nearly 99% of cases are treatable when caught at Stage I.
  

• The disease develops slowly, usually over 10 to 15 years, which means there's a wide window for detection.
  

• Close to half of all cases are linked to things we can change: diet, body weight, physical activity, alcohol, and smoking.
  

• Emerging research shows a meaningful connection between the gut microbiome and colon cancer development.
  

• Australia's National Bowel Cancer Screening Program offers free at-home screening, and participating can reduce bowel cancer death risk by 40%.

Disclaimer: This guide is not intended to diagnose, treat, cure, or prevent any disease or medical condition. It is designed for general wellness and education and does not claim to provide therapeutic benefits. Always consult with a qualified healthcare professional before making any changes to your health or wellness routine. Supplements should not replace a balanced diet. Always read the label.

Colorectal cancer is the second leading cause of cancer death in Australia. Around 15,000 Australians are diagnosed with bowel cancer each year, and more than 5,350 don't survive it. Those numbers are heavy. But they only tell part of the story.

The part that often gets lost is this: colon cancer is one of the most preventable and treatable cancers when it's found early. The five-year survival rate for Stage I disease (where the cancer is still confined to the inner lining of the colon) sits at approximately 99%. For Stage IV (where it has spread to distant organs), that drops to around 13%. The difference between catching it early and catching it late is genuinely life-changing.

There's also a trend worth knowing about. While overall colon cancer rates in Australia have dropped by 33% since 2001, rates among Australians aged 30 to 39 have tripled in the same period. One in nine new diagnoses now occurs in someone under 50. Researchers are still working to understand why, but diet, obesity, and changes to the gut microbiome are among the leading hypotheses.

This guide walks through what colon cancer is, how it develops, what the risk factors look like, what the latest research says about gut bacteria, and the practical steps that can support colon health and early detection.

What colon cancer actually is

Colon cancer begins when cells lining the colon start growing abnormally and form a small growth called a polyp. The colon is the longest section of the large intestine. It's the part of your digestive system that absorbs water and nutrients from digested food before waste moves towards the rectum (the final 12 to 15 centimetres before the anus). Cancer that starts in the rectum is called rectal cancer. Colorectal cancer is simply the umbrella term that covers both.

Most polyps are harmless. But a specific type called adenomatous polyps (sometimes shortened to adenomas) can pick up genetic mutations over time and eventually progress to cancer. Around 75% of colorectal cancers start from these adenomatous polyps, though only about 5% of adenomas ever become cancerous. Larger polyps (over 10 millimetres) tend to progress faster.

There's also a clinical difference between where the cancer sits. Right-sided colon cancers tend to be silent until more advanced stages, often showing up first as iron-deficiency anaemia (a drop in red blood cells caused by slow, ongoing blood loss that isn't visible to the naked eye). Left-sided and rectal cancers are more likely to cause noticeable changes like visible bleeding or shifts in bowel habits.

Colon cancer in Australia

According to Cancer Australia and the Australian Institute of Health and Welfare, an estimated 14,784 Australians will be diagnosed with bowel cancer in 2025. The lifetime risk is 1 in 23 overall (1 in 21 for males, 1 in 25 for females) by age 85. Bowel cancer accounts for roughly 11% of all cancer deaths in the country. The encouraging news is that five-year survival has improved steadily, from 52% in 1987–1991 to 72% in 2017–2021, thanks to advances in screening and treatment.

How colon cancer develops

Colon cancer doesn't appear suddenly. It follows a slow, step-by-step process that typically takes 10 to 15 years.

The foundational model for this process was described in a landmark 1988 New England Journal of Medicine study by Fearon and Vogelstein. They mapped out how normal colon cells gradually accumulate genetic damage, moving through a series of changes before eventually becoming cancerous. That long timeline is actually good news for detection. It means there is a wide window in which doctors can find and remove precancerous polyps before they ever turn dangerous.

The adenoma-to-cancer sequence

The progression follows a recognisable pattern of genetic damage. Think of it as a chain of safety locks being broken one at a time.

First, a gene called APC (which normally acts as a brake on cell growth) is lost or damaged. This is the initiating event, found in roughly 67% of even small polyps. Next, another gene called KRAS becomes overactive and starts pushing cells to multiply too quickly. Finally, a gene called TP53 (which normally triggers damaged cells to self-destruct) stops working. When TP53 is lost, cells that should be destroyed instead keep growing and can become invasive.

Three molecular pathways drive most colorectal cancers. The chromosomal instability pathway accounts for 65 to 70% of cases that arise without inherited genetic conditions, and follows the classical sequence above. The microsatellite instability pathway, caused by faulty DNA repair machinery, can produce tumours more quickly, sometimes in just a few years. The serrated neoplasia pathway operates through a different mechanism of gene silencing altogether.

None of this is something you need to memorise. The key point is that colon cancer follows a slow, predictable progression, and that gives screening programmes a real opportunity to catch it early.

When genetics plays a role

Roughly 70 to 80% of colorectal cancers are what doctors call sporadic, meaning they happen without a known inherited genetic cause. A further 10 to 20% show some family clustering, and 2 to 5% are caused by specific hereditary conditions.

Lynch syndrome is the most common hereditary colorectal cancer condition. It's caused by inherited faults in DNA repair genes and carries a lifetime cancer risk of 10 to 80%, depending on which gene is involved. The average age of diagnosis is around 44, roughly two decades earlier than for non-hereditary cases. Familial adenomatous polyposis (FAP) is rarer but more severe, causing hundreds or even thousands of polyps to develop in the colon from adolescence. Without preventive surgery, the lifetime cancer risk approaches 100%.

If bowel cancer runs in your family, it's worth having a conversation with your GP about whether earlier or more frequent screening would be appropriate.

Symptoms of colon cancer

This is the thing that catches many people off guard: early-stage colon cancer often has no symptoms at all. That is the main reason screening programmes exist. When symptoms do show up, they generally mean the cancer has already progressed.

The symptoms of colon cancer to be aware of include:

• Persistent blood in the stool. This can be bright red (more common with left-sided or rectal tumours) or dark and tarry (more common with right-sided tumours).

• Sustained changes in bowel habits. This might look like alternating between diarrhoea and constipation, or noticing that your stool is narrower than usual.

• Unexplained abdominal pain or cramping that doesn't go away.

• Unintended weight loss.

• Ongoing fatigue or weakness that isn't explained by other factors.

• Iron-deficiency anaemia, which is a particularly important signal for right-sided colon cancers. It happens when slow, ongoing blood loss (invisible to the eye) gradually reduces your red blood cell count, leaving you feeling exhausted and breathless.

• A feeling that the bowel hasn't completely emptied, which is more common with rectal cancers.

Here's the tricky part: many of these symptoms of colon cancer overlap with far more common and less serious conditions like haemorrhoids, irritable bowel syndrome, or even just dietary changes. That overlap is one of the reasons younger adults in particular tend to experience delays in diagnosis. A Queensland population study found that people with early-onset colorectal cancer were more likely to be diagnosed at Stage III or IV (66% versus 59% in older patients), partly because their symptoms were initially put down to something less serious.

None of this is meant to alarm you. Most people with these symptoms won't have colon cancer. But if you're experiencing any of them persistently, it's worth seeing your GP to get things checked. Early investigation is always a good idea.

Risk factors

An estimated 45 to 47% of colorectal cancers are linked to lifestyle and dietary factors that can be changed, according to a 2023 analysis in Scientific Reports. The remainder comes down to age, genetics, and other factors outside our control.

Age and the early-onset trend

Age remains the single strongest risk factor. Most cases still occur in people over 50. But the picture is shifting in a way that deserves attention. In Australia, colon cancer rates among 30 to 39-year-olds have risen from 6.3 to an estimated 19 per 100,000 between 2000 and 2025. Bowel Cancer Australia reports that 1,716 Australians under 50 are now diagnosed each year. Diet, obesity, and changes to the gut microbiome are all being investigated as potential contributors.

Inflammatory bowel disease

Both ulcerative colitis and Crohn's disease increase colon cancer risk through ongoing inflammation in the bowel lining. While only 1 to 2% of IBD patients develop colorectal cancer, the risk rises notably once someone has lived with the condition for longer than eight years. Chronic inflammation creates a cycle of tissue damage and repair that, over time, increases the chance of genetic errors that can lead to cancer.

Red and processed meat

The International Agency for Research on Cancer classified processed meat as a Group 1 carcinogen (meaning the evidence for a cancer link is strong) and red meat as Group 2A (probably carcinogenic) for colorectal cancer in 2015. Each 50-gram daily serving of processed meat increases colon cancer risk by about 18%.

A quick note on that Group 1 label, because it can be misleading: it describes the strength of the evidence, not the size of the risk. Processed meat and tobacco share the same evidence category, but they are nowhere near equally dangerous. The classification means scientists are confident the link exists, not that eating bacon is as risky as smoking.

The mechanism is well understood. Preservatives like sodium nitrite and nitrates, common in bacon, sausages, and deli meats, interact with heme iron (the type of iron found in red meat) in the digestive tract to form compounds called N-nitroso compounds. These directly damage DNA. Cooking meat at high temperatures adds further harmful byproducts.

Average Australian red meat consumption sits at about 565 grams per week, roughly 24% above the Cancer Council Australia guideline maximum of 455 grams cooked weight.

Ultra-processed foods

Ultra-processed foods (UPFs) are industrially manufactured products that contain ingredients you wouldn't use in a home kitchen: artificial sweeteners, emulsifiers, stabilisers, and various additives. Think ready-to-eat meals, packaged snacks, soft drinks, and mass-produced breads with long ingredient lists.

A 2022 cohort study published in The BMJ, tracking nearly 200,000 people over more than 25 years, found that men who ate the most ultra-processed foods had a 29% higher risk of colorectal cancer compared to those who ate the least. A 2024 systematic review in Cancers has reinforced the broader pattern, though this area of research is still younger than the evidence around processed meat.

How might UPFs contribute to risk? Research points to several pathways: food additives like emulsifiers may disrupt the gut microbiome and damage the protective mucus layer lining the intestine; industrial processing introduces chemical contaminants; excess sugars drive inflammation and DNA damage; and the overall nutritional profile (high in energy, low in fibre and protective nutrients) contributes to weight gain and obesity.

Other established risk factors

Physical inactivity independently increases risk. A meta-analysis of 126 studies by the US National Cancer Institute found the most active people had a 19% lower colon cancer risk. Only 24% of Australians meet the national physical activity guidelines.

Obesity affects 65.8% of Australian adults and raises colorectal cancer risk by about 5% per five-unit increase in BMI (body mass index, a measure of weight relative to height). The connection works through chronic low-grade inflammation, insulin resistance (where your body's cells stop responding efficiently to insulin), and changes to hormones that can encourage cancer cell growth.

Type 2 diabetes independently increases colon cancer risk by approximately 47%, even after accounting for obesity.

Alcohol carries a 7% increased risk per 10 grams of daily ethanol. When your body breaks down alcohol, it produces a toxic byproduct called acetaldehyde that damages cells, creates oxidative stress (an imbalance that harms DNA), and reduces absorption of protective nutrients like folate.

Smoking is linked to both the formation of polyps and higher colorectal cancer mortality.

The gut microbiome and colon cancer

The relationship between the trillions of bacteria living in your gut and colorectal cancer is one of the fastest-moving areas of cancer research. The findings are still emerging, and most should be understood as associations rather than confirmed cause-and-effect. But the evidence is becoming increasingly detailed and consistent.

At the centre of this research is a concept called dysbiosis, which simply means an imbalance in the gut's microbial ecosystem. When you lose diversity in your gut bacteria, when beneficial species decline, and when potentially harmful species gain a foothold, the environment in your colon changes in ways that may favour cancer development: chronic inflammation, weakened immune surveillance, and even direct damage to DNA.

Three bacteria with the strongest links

Researchers have identified three bacterial species that show up repeatedly in colon cancer studies across different populations worldwide. They each work through different mechanisms, and they often co-exist in the same tumour environment.

Fusobacterium nucleatum is a bacterium that normally lives in the mouth and is rarely found in a healthy lower gut, but it's consistently enriched in colorectal cancer tissue. A 2024 Nature study found that only a specific subclade of this species dominates the cancer niche. It appears to promote cancer through several routes: breaking down the protective barrier that lines the intestine, switching on growth signals that push cells to multiply uncontrollably, and binding to immune cells in a way that effectively shields the tumour from the body's immune defences.

Enterotoxigenic Bacteroides fragilis (ETBF) is a strain of a common gut bacterium that produces a specific toxin. This toxin directly damages the junctions between intestinal cells (the connections that hold the gut lining together as a barrier), which triggers the same growth signalling that drives abnormal cell multiplication. ETBF also provokes a chronic inflammatory immune response, creating a cycle of tissue damage and repair that can accelerate the path towards cancer.

pks+ Escherichia coli are strains of E. coli that produce a toxin called colibactin, which directly damages DNA. In a landmark 2020 Nature study, researchers grew miniature human intestinal models in a lab and exposed them to these bacteria for five months. The result was a distinctive pattern of DNA mutations. When they searched a database of 5,876 human cancer genomes, the same mutational pattern turned up, predominantly in colorectal cancer. It's one of the most direct demonstrations yet of a specific bacterium contributing to cancer-associated genetic damage in human tissue.

These three species don't typically work in isolation. The current understanding, described in the driver-passenger model proposed in Nature Reviews Microbiology, is that pks+ E. coli tends to act early by inflicting DNA damage, while F. nucleatum and ETBF contribute to tumour growth and progression later through inflammation and immune suppression.

A 2025 Nature Medicine analysis of 3,741 stool samples from 18 international study groups confirmed reproducible colon cancer microbiome signatures across different populations, which raises the possibility of microbiome-based screening tools in the future.

Bacteria that are consistently depleted

The other side of the picture matters too. Bacteria that are consistently reduced in colon cancer patients include major butyrate producers: Faecalibacterium prausnitzii, Roseburia species, and Bifidobacterium species. Butyrate is a short-chain fatty acid (a type of beneficial compound produced when gut bacteria ferment dietary fibre) that helps maintain the gut lining, calms inflammation, and supports healthy immune function. When the bacteria that produce it decline, the colon loses a layer of protection.

Metabolites and the chemical environment of the colon

The substances that gut bacteria produce (called metabolites) act as intermediaries between the microbiome and cancer risk.

Butyrate is the most studied protective metabolite. It provides approximately 70% of the energy for the cells lining the colon (called colonocytes) and has well-documented anti-inflammatory and tumour-suppressing effects. When fibre intake drops, butyrate production drops with it.

On the other side, an imbalanced gut can produce harmful metabolites. Certain bacteria convert bile acids (substances your liver makes to help digest fat) into secondary bile acids, particularly a compound called deoxycholic acid. These secondary bile acids are harmful to colon cells: they generate reactive oxygen species (unstable molecules that damage DNA), trigger inflammatory signalling, and, as a 2024 Immunity study demonstrated, suppress the ability of immune cells to fight tumours.

Diet and lifestyle factors that support colon health

Australia's fibre gap

The World Cancer Research Fund judges dietary fibre as having 'convincing' evidence for reducing colorectal cancer risk. A dose-response meta-analysis of 25 prospective studies in the BMJ, covering more than 1.7 million participants, found a 10% risk reduction for every additional 10 grams of daily fibre. The large European EPIC study, tracking over 500,000 people, concluded that doubling fibre intake could reduce colorectal cancer risk by approximately 40% in populations with low intake.

And yet, 83% of Australians don't meet the Suggested Dietary Target for fibre. The average daily intake is roughly 20 to 23 grams, well short of the 28 grams recommended for women and 38 grams for men.

CSIRO research has flagged something they call an 'Australian paradox': overall fibre consumption looks reasonable by international standards, yet our colorectal cancer rates remain among the highest in the world. The explanation seems to lie in which types of fibre Australians eat. We get enough insoluble fibre (the kind found in wheat bran and vegetable skins), but very little resistant starch, a specific type of fibre that reaches the colon intact and is fermented by bacteria into butyrate. Current resistant starch intake is estimated at just 5 grams per day, against a target of roughly 20 grams.

Good dietary sources of resistant starch include cooked and cooled potatoes and rice, green bananas, legumes, and oats.

Whole grains and Mediterranean-style eating

The WCRF's 2017 report found that approximately 3 servings (90 grams) of whole grains daily reduces colorectal cancer risk by about 17%, rated as 'convincing' evidence. Mediterranean-style dietary patterns also show a probable protective association, with a pooled Italian study of over 10,000 participants finding roughly 48% risk reduction at the highest level of adherence.

Calcium from low-fat dairy products like milk, yoghurt, and cheese shows probable protective effects too. And folate (found in leafy greens, legumes, and fortified foods) shows a 12% risk reduction at highest versus lowest intake, with the strongest effect in people who drink moderate to high amounts of alcohol.

Physical activity makes a measurable difference

In 2025, the CO21 CHALLENGE trial became the first randomised controlled trial to show that structured exercise directly improves colon cancer survival. Participants had a 28% lower risk of cancer returning and 37% lower mortality over three years. This built on decades of observational evidence showing 19 to 50% risk reductions among the most physically active people.

Exercise helps by improving the speed at which food moves through the digestive tract, by regulating hormones and insulin levels, and by reducing systemic inflammation.

Australia's guidelines recommend 2.5 to 5 hours of moderate-intensity activity per week. Fewer than one in four adults meets that target. The AIHW estimates that physical inactivity accounts for 16% of the bowel cancer burden in Australia.

Practical steps supported by the evidence

The strategies with the strongest research behind them for supporting colon health include:

Eating a plant-rich, high-fibre diet with whole grains, fruits, vegetables, and legumes. Pay particular attention to resistant starch sources: cooked and cooled potatoes, green bananas, oats, and legumes. Aim for at least 28 to 38 grams of total fibre daily.

Keeping red meat to no more than 455 grams of cooked weight per week, and reducing processed meats like bacon, sausages, and deli meats as much as you can.

Cutting back on ultra-processed foods and sugary drinks.

Maintaining a healthy body weight. Excess body fat drives chronic inflammation and hormonal changes that can encourage cancer cell growth.

Moving your body regularly. At least 150 minutes of moderate-intensity exercise per week, and avoid sitting for long unbroken stretches.

Being mindful of alcohol. Less is better.

Not smoking. Long-term smoking is linked to both polyp formation and higher colorectal cancer mortality.

Early detection saves lives

The survival gap between early and late-stage diagnosis is the single most actionable piece of information in this entire guide. Stage I has a five-year survival rate of 99%. Stage IV drops to 13%. When bowel cancer is found early, more than 90% of cases can be successfully treated.

How Australia's screening programme works

Australia's National Bowel Cancer Screening Program (NBCSP) sends eligible Australians a free at-home stool test every two years. The test is called an immunochemical faecal occult blood test (iFOBT), and it works by detecting microscopic traces of blood in the stool, amounts too small to see with the naked eye, that may indicate polyps, adenomas, or early cancers. A positive result leads to a referral for colonoscopy, during which any pre-cancerous polyps can be found and removed in the same procedure, directly preventing cancer from developing.

From 1 July 2024, Australians aged 45 to 49 can opt in to the programme by requesting a free kit. Over 77,500 people in this age group had requested kits in the first six months. The automatic invitation range remains 50 to 74, with screening every two years.

The programme works. People aged 50 to 69 whose cancer was detected through the NBCSP had a 40% lower risk of dying from bowel cancer than those not invited to screen. It's estimated to save around 500 lives every year.

But participation remains well below where it needs to be. The 2022–2023 rate was 41.7%, against a national target of 55%. That means nearly six in ten invited Australians don't return their free test.

If you've received a kit, please use it. If you're aged 45 to 49 and haven't opted in, you can request a free kit through the National Cancer Screening Register. It's a simple thing that can make a real difference.

Supporting your gut health

The following section covers general gut health support based on current evidence. These are not claims about cancer treatment or prevention.

Why microbiome diversity matters

Your gut is home to approximately 1,000 different microbial species. Greater diversity in this community is consistently linked to better health outcomes. A 2023 Science study from the University of Oxford found that communities of up to 50 bacterial species suppressed harmful pathogen growth up to 1,000 times more effectively than any single species, working through a mechanism where the beneficial bacteria essentially starve the harmful ones of nutrients.

Research into healthy centenarians has also found that long-living populations tend to maintain higher gut diversity than younger adults, with particular enrichment of short-chain fatty acid-producing bacteria.

Fibre, fermentation, and butyrate

When dietary fibre reaches the colon undigested, your gut bacteria ferment it into short-chain fatty acids, primarily acetate, propionate, and butyrate. Butyrate in particular plays several protective roles: it maintains the integrity of the gut barrier (the lining that keeps the contents of your digestive system where they belong), supports anti-inflammatory signalling, and helps maintain the low-oxygen conditions that beneficial bacteria thrive in.

Resistant starch is the most effective substrate for butyrate production. Other butyrate-supporting fibres include inulin, pectin, and oat beta-glucan. Prebiotics (non-digestible compounds that selectively feed beneficial gut bacteria) like galacto-oligosaccharides (GOS) and fructo-oligosaccharides (FOS) also consistently promote the growth of Bifidobacterium populations at doses of 10 grams or more per day.

It's worth noting that approximately 70% of the body's immune system is associated with gut-associated lymphoid tissue (GALT), making the gastrointestinal tract the largest immune organ. Short-chain fatty acids, particularly butyrate, act as key communicators in the ongoing conversation between your gut bacteria and your immune system.

Fermented foods and microbial diversity

The most significant clinical evidence for fermented foods comes from the Stanford study by Wastyk, Sonnenburg et al. (Cell, 2021). In a 17-week randomised trial of 36 healthy adults, a high-fermented-food diet that included yoghurt, kefir, fermented vegetables, and kombucha steadily increased microbiota diversity while reducing 19 inflammatory markers, including interleukin-6 (a protein involved in inflammation). Interestingly, a high-fibre diet alone did not increase diversity over the same period, suggesting fermented foods work through a distinct mechanism.

Individual fermented foods carry varying levels of evidence. Yoghurt with live cultures has the largest body of research linking regular consumption to favourable metabolic markers. Kefir, which contains a wide range of bacteria and yeasts, has shown promising effects on gut bacteria composition and inflammatory markers in multiple small randomised controlled trials. Kombucha and fermented vegetables have more preliminary evidence, though the early findings are encouraging.

At Nourishme Organics, we stock a range of fermentation starter cultures, probiotics, and prebiotic supplements to support gut health as part of a broader dietary approach. Our founder, Kriben Govender, is a Registered Food Scientist and Nutritionist whose own health journey led him to microbiome science and fermentation. That personal experience, combined with ongoing education through the Gut Health Gurus podcast, informs every product we stock. We believe in supporting a diverse, well-nourished gut microbiome through whole foods, fermented foods, and targeted supplementation, because it aligns with the strongest available evidence for long-term digestive wellbeing.

If you're new to gut health, our beginners start here page is a good place to get oriented. If you'd like to start making your own fermented foods, we have step-by-step guides for milk kefir, water kefir, kombucha, and probiotic yoghurt.

Frequently asked questions

What is colon cancer?

Colon cancer is a type of cancer that starts in the colon, the longest section of the large intestine. It usually begins as a small growth called a polyp that picks up genetic damage over time and can eventually become cancerous. Colorectal cancer is the broader term covering cancer of both the colon and the rectum.

What are the symptoms of colon cancer?

The symptoms of colon cancer can include persistent blood in the stool, ongoing changes in bowel habits (such as diarrhoea, constipation, or narrower stools), unexplained abdominal pain, unintended weight loss, chronic fatigue, and iron-deficiency anaemia. Early-stage colon cancer often has no symptoms at all, which is why regular screening matters.

Who is most at risk?

Age is the strongest risk factor, with most cases occurring after 50. Other significant risk factors include family history, hereditary conditions like Lynch syndrome, inflammatory bowel disease, obesity, physical inactivity, heavy alcohol consumption, smoking, and a diet high in processed meat and low in fibre.

Can colon cancer be prevented?

Not entirely, but close to half of all cases are linked to factors that can be changed. A high-fibre diet, limited processed and red meat, healthy body weight, regular exercise, moderate alcohol consumption, and not smoking all reduce risk. Regular screening can also catch and remove precancerous polyps before they develop into cancer.

How does the gut microbiome connect to colon cancer?

Research has identified specific gut bacteria that are consistently found in colon cancer tissue, including Fusobacterium nucleatum, enterotoxigenic Bacteroides fragilis, and pks+ Escherichia coli. These bacteria appear to contribute through direct DNA damage, chronic inflammation, and suppressing immune responses. Beneficial butyrate-producing bacteria are consistently depleted in colon cancer patients. Most evidence is still in the association stage rather than confirmed cause-and-effect, but the research is advancing quickly.

What is the National Bowel Cancer Screening Program?

Australia's NBCSP sends eligible Australians a free at-home stool test every two years that detects tiny traces of blood not visible to the naked eye. Australians aged 50 to 74 receive automatic invitations. Those aged 45 to 49 can now opt in by requesting a free kit through the National Cancer Screening Register.

At what age should I start screening?

Australians aged 50 to 74 are automatically invited to participate. Since July 2024, those aged 45 to 49 can opt in. If you have a family history of bowel cancer, Lynch syndrome, or inflammatory bowel disease, have a conversation with your GP about whether you should start screening earlier.

Why is dietary fibre important for colon health?

Fibre is fermented by gut bacteria into short-chain fatty acids, particularly butyrate, which provides energy to the cells lining the colon and has anti-inflammatory and protective effects. Resistant starch is the most effective type of fibre for butyrate production. Despite this, 83% of Australians don't meet recommended fibre targets.

Can fermented foods support gut health?

A 2021 Stanford University trial showed that a diet rich in fermented foods (including yoghurt, kefir, fermented vegetables, and kombucha) increased gut microbiome diversity and reduced inflammatory markers over 17 weeks. While fermented foods are not a treatment for any disease, including them as part of a varied diet aligns with current evidence for supporting microbiome diversity and digestive wellbeing.

Are younger people at risk of colon cancer?

Yes, and increasingly so. While overall rates have declined since 2001, colon cancer rates among Australians aged 30 to 39 have tripled in that same period. One in nine new diagnoses now occurs in someone under 50. Younger adults should take persistent bowel symptoms seriously and see their GP.

Note from Nourishme Organics: Colon cancer is a serious diagnosis, but it's also a disease where the evidence consistently shows that early detection and everyday choices make a real difference. If you're eligible for screening, please take the test. If you're under 50 with persistent symptoms, see your doctor. And if you're looking for ways to support your gut health through diet, fermented foods, and fibre, explore our full range of gut health products